ARCHIVES

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

This article is from The Cancer Letter archive.

Vol. 40 No. 06 | February 7, 2014

Download PDF Visit The Full Archive

Related Articles

Lasker Pushes NCI To Get Research Results Quicker, Into Practice Sooner

May 31, 1974

In Brief: Hawaii Study finds No Increase Risk for Large Bowell Cancer From High Intake Of Saturated Fat

October 12, 1984

Vanderbilt-Ingram wins third SPORE grant.

September 19, 2003

Coalitions Urges Members To Call, Write, Congress

May 3, 1991

Yates Named DRCCA AD To Head Centers, CCOP, Organ Sites: CCOP Workshops Listed

February 26, 1982

Autologous BMT Equivalent To Allogeneic For Myeloma

December 31, 2010